Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Insider Trading Anomaly Lives In The US And Abroad: Profitability of Insider Trading in Netherlands

The insider trading anomaly has been documented in the US stock market for more than 40 years. When there’s a consensus among insiders, returns are especially high. Former academicians Josef Lakonishok and Inmoo Lee, who now both work in the private sector, calculated insider trading returns from 1975 to 1995 and found 7.7% excess raw returns and 4.8% risk adjusted returns. 

This type of result isn’t limited to the US markets. They also hold true in other parts of the world. For example, a 2003 study by Dutch scientists show evidence for the profitability of insider trading in the Netherlands

Dutch insiders have been required to report their transactions on Euronext Amsterdam since April 1999, so the study is based on pretty recent insider trading data. Insiders appear to be contrarian investors in the Netherlands as well; they buy after negative returns and they sell after a positive performance. The study found that during the first 20 trading days after the transaction, insider purchases returned 2.23% and insider sales returned -1.91%. These abnormal returns are statistically significant. 

Profitability of insider trading anomaly

Source: Biesta, Doeswijk, and Donker (2003)

But the buy and hold abnormal returns are more significant. The portfolio of insider purchases had a cumulative excess return of 11.3% after 6 months, whereas the portfolio of insider sales had -2.4% in excess returns during the same time period. However, these results were in comparison to the total market returns and didn’t adjust for size or value effects. When the authors adjusted these two effects, the abnormal return of the purchase portfolio dropped to 8.0% but the abnormal return of insider sales portfolio increased to -7.3%. The results were also based on a 6 month holding period, and the annualized abnormal returns were in double digits.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!